Conservative cabinet minister “accepts the recommendation of the country’s leading researchers.” The subject is multiple sclerosis, the decision is to refrain from funding studies into the effectiveness of a maverick therapy Colleague Cosh and others here have covered at some length, and in the context, Leona Aglukkaq’s decision seems rather courageous.